These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31205505)

  • 1. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma.
    Ponziani FR; Nicoletti A; Gasbarrini A; Pompili M
    Ther Adv Med Oncol; 2019; 11():1758835919848184. PubMed ID: 31205505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Hepatocellular Carcinoma.
    Tao X; Wang N; Qin W
    Gastrointest Tumors; 2015 May; 2(1):33-40. PubMed ID: 26673641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, fatty liver disease, and hepatocellular carcinoma.
    Chu H; Williams B; Schnabl B
    Liver Res; 2018 Mar; 2(1):43-51. PubMed ID: 30416839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma.
    Yu Q; Wu L; Ji J; Feng J; Dai W; Li J; Wu J; Guo C
    J Hepatocell Carcinoma; 2020; 7():271-288. PubMed ID: 33150145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.
    Wan MLY; El-Nezami H
    Hepatobiliary Surg Nutr; 2018 Feb; 7(1):11-20. PubMed ID: 29531939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy.
    Luo W; Guo S; Zhou Y; Zhao J; Wang M; Sang L; Chang B; Wang B
    Front Microbiol; 2022; 13():873160. PubMed ID: 35572649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
    Jiang JW; Chen XH; Ren Z; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma.
    Ni J; Huang R; Zhou H; Xu X; Li Y; Cao P; Zhong K; Ge M; Chen X; Hou B; Yu M; Peng B; Li Q; Zhang P; Gao Y
    Front Microbiol; 2019; 10():1458. PubMed ID: 31293562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of gut microbiota in hepatocellular carcinoma.
    Li K; Liu J; Qin X
    J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting gut flora to prevent progression of hepatocellular carcinoma.
    Darnaud M; Faivre J; Moniaux N
    J Hepatol; 2013 Feb; 58(2):385-7. PubMed ID: 22940407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.
    Zhang HL; Yu LX; Yang W; Tang L; Lin Y; Wu H; Zhai B; Tan YX; Shan L; Liu Q; Chen HY; Dai RY; Qiu BJ; He YQ; Wang C; Zheng LY; Li YQ; Wu FQ; Li Z; Yan HX; Wang HY
    J Hepatol; 2012 Oct; 57(4):803-12. PubMed ID: 22727732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma.
    Shen S; Khatiwada S; Behary J; Kim R; Zekry A
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.
    Lapidot Y; Amir A; Nosenko R; Uzan-Yulzari A; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Safran M; Ben-Ari Z
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32546668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.
    Roderburg C; Luedde T
    Gut Microbes; 2014 Jul; 5(4):441-5. PubMed ID: 25006881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
    Kang Y; Cai Y; Yang Y
    Liver Cancer; 2022 Apr; 11(2):113-125. PubMed ID: 35634424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctly altered gut microbiota in the progression of liver disease.
    Xie G; Wang X; Liu P; Wei R; Chen W; Rajani C; Hernandez BY; Alegado R; Dong B; Li D; Jia W
    Oncotarget; 2016 Apr; 7(15):19355-66. PubMed ID: 27036035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.
    Spanu D; Pretta A; Lai E; Persano M; Donisi C; Mariani S; Dubois M; Migliari M; Saba G; Ziranu P; Pusceddu V; Puzzoni M; Astara G; Scartozzi M
    World J Hepatol; 2022 Jul; 14(7):1319-1332. PubMed ID: 36158925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.
    Yamada S; Takashina Y; Watanabe M; Nagamine R; Saito Y; Kamada N; Saito H
    Oncotarget; 2018 Feb; 9(11):9925-9939. PubMed ID: 29515780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma.
    Yoshikawa S; Taniguchi K; Sawamura H; Ikeda Y; Asai T; Tsuji A; Matsuda S
    Explor Target Antitumor Ther; 2023; 4(4):556-568. PubMed ID: 37720344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.